Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study
To access this article, please choose from the options below
D.B. has nothing to disclose. J.J.G. has nothing to disclose. M.T. has nothing to disclose. K.S. has nothing to disclose. C.E. has nothing to disclose. O.C. has nothing to disclose.
PII: S0015-0282(09)03514-6
doi:10.1016/j.fertnstert.2009.08.036
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

